Rationale Behind Targeting Fibroblast Activation Protein–Expressing Carcinoma-Associated Fibroblasts as a Novel Chemotherapeutic Strategy

Documenti analoghi

• Targeting Carcinoma-Associated Fibroblasts Within the Tumor Stroma With a Fibroblast Activation Protein-Activated Prodrug
  di: Brennen, W. Nathaniel, et al.
  Pubblicazione: (2012)
• Rationale for bipolar androgen therapy (BAT) for metastatic prostate cancer
  di: Isaacs, John T., et al.
  Pubblicazione: (2017)
• Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin
  di: LeBeau, Aaron M., et al.
  Pubblicazione: (2009)
• Iterative Design of Emetine-Based Prodrug Targeting Fibroblast Activation Protein (FAP) and Dipeptidyl Peptidase IV DPPIV Using a Tandem Enzymatic Activation Strategy
  di: Akinboye, Emmanuel S., et al.
  Pubblicazione: (2016)
• Overcoming stromal barriers to immuno-oncological responses via fibroblast activation protein-targeted therapy
  di: Brennen, W Nathaniel, et al.
  Pubblicazione: (2020)